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The novel coronavirus disease 2019 (COVID-19) was first diagnosed in Wuhan, China in December 2019 and initially presented in a small group of patients with severe acute respiratory syndrome coronavirus-2 (SARS CoV-2). Over the past 6 months, COVID-19 has spread throughout the world, and on March 11, 2020, the World Health Organization officially declared this to be a pandemic. According to the Centers for Disease Control, as of August 6, 2020, nearly 18.7 million cases have now been diagnosed worldwide with 705,000 deaths. In the United States (US), 4.8 million cases have been reported with about 157,000 deaths. It is clear that COVID-19 is a highly contagious disease, and it has dramatically affected the management of patients with cancer in the US, in Europe, in Asia, and in countries around the world.

In this issue, we have incorporated 6 commentaries that describe how to optimally manage and treat patients with cancer during the COVID-19 pandemic. We provide a practical approach that has been taken in Asia, Europe, and the US, and we hope that the readers will find these to be useful when considering how to manage their patients presenting with colorectal cancer and other gastrointestinal cancers.
